caa a22 4500 606178805 CHVBK 20210128100758.0 cr unu---uuuuu 210128e20151201xx s 000 0 eng 10.1007/s11136-015-1028-1 doi (NATIONALLICENCE)springer-10.1007/s11136-015-1028-1 Caring for relatives with lung cancer in Europe: an evaluation of caregivers' experience [Elektronische Daten] [Jacek Jassem, John Penrod, Amir Goren, Isabelle Gilloteau] Purpose: Informal caregiving for cancer patients is associated with substantial costs and negative health impact. This study investigated the health, humanistic and economic consequences of caring for lung cancer patients in five European Union (EU) countries. Methods: The study included respondents to the 2010/2011 EU National Health and Wellness Survey from France, Germany, Italy, Spain and the United Kingdom who self-reported being caregivers of a relative with lung cancer (n=107) or non-caregivers (n=103,868). Bivariate and multivariable analyses tested the association of caregiving with stress-related comorbidities; health-related quality of life (HRQoL), using the Short Form-12; healthcare resource use; and work productivity/activity impairment, using the Work Productivity and Activity Impairment (WPAI) questionnaire. Costs were based on absenteeism and presenteeism rates. Results: Caregivers versus non-caregivers had significantly higher odds of depression, insomnia, headache and gastrointestinal symptoms, and worse HRQoL. Caregivers reported significantly higher rates of presenteeism-related, overall work and activity impairment; higher odds of impairment across WPAI measures; and higher annual indirect costs with presenteeism and overall work impairment. Conclusions: Caregiving for lung cancer patients is associated with significant health/work impairments and costs, highlighting a need for increased, personalized caregiver support. Springer International Publishing Switzerland, 2015 Caregivers nationallicence Health-related quality of life nationallicence Lung cancer nationallicence Work Productivity and Activity Impairment nationallicence Jassem Jacek Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland aut Penrod John Global Health Economics and Outcomes, Bristol-Myers Squibb, Princeton, NJ, USA aut Goren Amir Health Outcomes Practice, Health Economics and Outcomes Research, Kantar Health, 11 Madison Ave, Fl 12, 10010, New York, NY, USA aut Gilloteau Isabelle Global Health Economics and Outcomes, Bristol-Myers Squibb, Princeton, NJ, USA aut Quality of Life Research Springer International Publishing 24/12(2015-12-01), 2843-2852 0962-9343 24:12<2843 2015 24 11136 https://doi.org/10.1007/s11136-015-1028-1 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s11136-015-1028-1 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Jassem Jacek Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland aut NATIONALLICENCE 700 1- Penrod John Global Health Economics and Outcomes, Bristol-Myers Squibb, Princeton, NJ, USA aut NATIONALLICENCE 700 1- Goren Amir Health Outcomes Practice, Health Economics and Outcomes Research, Kantar Health, 11 Madison Ave, Fl 12, 10010, New York, NY, USA aut NATIONALLICENCE 700 1- Gilloteau Isabelle Global Health Economics and Outcomes, Bristol-Myers Squibb, Princeton, NJ, USA aut NATIONALLICENCE 773 0- Quality of Life Research Springer International Publishing 24/12(2015-12-01), 2843-2852 0962-9343 24:12<2843 2015 24 11136